Last 12 months
Inside the activity.
0 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 26, 2019 Filed Feb 28, 2019 23:53 UTC |
McCallion John D.EVP & Chief Financial Officer
|
Tax withholdingCommon Stock | 1,407 | $44.65 | $62,822.55 |
DisclosureSEC source: 0001209191-19-014759 · doc4.xml · nonDerivative · entry 2 McCallion John D. · CIK 0001709116 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,618 F2 · kind: Shares withheld to satisfy the Reporting Person's tax withholding obligation due on the Performance Share payout. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 23:53 UTC |
McCallion John D.EVP & Chief Financial Officer
|
GrantCommon Stock | 4,156 | $44.65 | $185,565.40 |
DisclosureSEC source: 0001209191-19-014759 · doc4.xml · nonDerivative · entry 1 McCallion John D. · CIK 0001709116 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,025 F1 · kind: Shares acquired from the payout of 2016-2018 Performance Share Award pursuant to the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 23:53 UTC |
Lippert Martin JEVP Global Tech & Operations
|
GrantRestricted Stock Units · Derivative | 15,118 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-014758 · doc4.xml · derivative · entry 4 Lippert Martin J · CIK 0001527888 · EVP Global Tech & Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,118 Underlying: Common Stock · 15,118 shares Expires not disclosed F4 · derivative.exercise_price: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock. F5 · derivative.exercise_date: The Restricted Stock Units vest in three installments on March 2, 2020, March 1, 2021 and March 1, 2022. F5 · derivative.expiration_date: The Restricted Stock Units vest in three installments on March 2, 2020, March 1, 2021 and March 1, 2022. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 23:53 UTC |
Lippert Martin JEVP Global Tech & Operations
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 45,363 | $0.00 Strike: $44.65 | $0.00 |
DisclosureSEC source: 0001209191-19-014758 · doc4.xml · derivative · entry 3 Lippert Martin J · CIK 0001527888 · EVP Global Tech & Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,363 Underlying: Common Stock · 45,363 shares Expires 2029-02-25 F3 · derivative.exercise_date: The options become exercisable in three installments on February 26, 2020, 2021 and 2022. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 23:53 UTC |
Lippert Martin JEVP Global Tech & Operations
|
Tax withholdingCommon Stock | 16,026 | $44.65 | $715,560.90 |
DisclosureSEC source: 0001209191-19-014758 · doc4.xml · nonDerivative · entry 2 Lippert Martin J · CIK 0001527888 · EVP Global Tech & Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,061 F2 · kind: Shares withheld to satisfy the Reporting Person's tax withholding obligation due on the Performance Share payout. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 23:53 UTC |
Lippert Martin JEVP Global Tech & Operations
|
GrantCommon Stock | 35,772 | $44.65 | $1,597,219.80 |
DisclosureSEC source: 0001209191-19-014758 · doc4.xml · nonDerivative · entry 1 Lippert Martin J · CIK 0001527888 · EVP Global Tech & Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,087 F1 · kind: Shares acquired from the payout of 2016-2018 Performance Share Award pursuant to the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 23:52 UTC |
Lee EstherEVP & Chief Marketing Officer
|
GrantRestricted Stock Units · Derivative | 4,032 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-014756 · doc4.xml · derivative · entry 3 Lee Esther · CIK 0001585015 · EVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,032 Underlying: Common Stock · 4,032 shares Expires not disclosed F3 · derivative.exercise_price: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock. F4 · derivative.exercise_date: The Restricted Stock Units vest in three installments on March 2, 2020, March 1, 2021 and March 1, 2022. F4 · derivative.expiration_date: The Restricted Stock Units vest in three installments on March 2, 2020, March 1, 2021 and March 1, 2022. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 23:52 UTC |
Lee EstherEVP & Chief Marketing Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 12,097 | $0.00 Strike: $44.65 | $0.00 |
DisclosureSEC source: 0001209191-19-014756 · doc4.xml · derivative · entry 2 Lee Esther · CIK 0001585015 · EVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,097 Underlying: Common Stock · 12,097 shares Expires 2029-02-25 F2 · derivative.exercise_date: The options become exercisable in three installments on February 26, 2020, 2021 and 2022. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 23:52 UTC |
Lee EstherEVP & Chief Marketing Officer
|
GrantCommon Stock | 12,776 | $44.65 | $570,448.40 |
DisclosureSEC source: 0001209191-19-014756 · doc4.xml · nonDerivative · entry 1 Lee Esther · CIK 0001585015 · EVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,513 F1 · kind: The Reporting Person acquired these deferred shares from the 2016-2018 Performance Shares pursuant to the MetLife, Inc. 2015 Stock and Incentive Compensation Plan and the MetLife Leadership Deferred Compensation Plan, under which Executive Officers may elect to defer receipt of such stock for a specific period of time. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 23:52 UTC |
Khalaf MichelPresident, U.S. Bus. and EMEA
|
GrantRestricted Stock Units · Derivative | 30,236 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-014755 · doc4.xml · derivative · entry 4 Khalaf Michel · CIK 0001535491 · President, U.S. Bus. and EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,236 Underlying: Common Stock · 30,236 shares Expires not disclosed F3 · derivative.exercise_price: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock. F4 · derivative.exercise_date: The Restricted Stock Units vest in three installments on March 2, 2020, March 1, 2021 and March 1, 2022. F4 · derivative.expiration_date: The Restricted Stock Units vest in three installments on March 2, 2020, March 1, 2021 and March 1, 2022. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 23:52 UTC |
Khalaf MichelPresident, U.S. Bus. and EMEA
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 90,726 | $0.00 Strike: $44.65 | $0.00 |
DisclosureSEC source: 0001209191-19-014755 · doc4.xml · derivative · entry 3 Khalaf Michel · CIK 0001535491 · President, U.S. Bus. and EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,726 Underlying: Common Stock · 90,726 shares Expires 2029-02-25 F2 · derivative.exercise_date: The options become exercisable in three installments on February 26, 2020, 2021 and 2022. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 23:52 UTC |
Khalaf MichelPresident, U.S. Bus. and EMEA
|
Disposition to issuerCommon Stock | 22,997 | $44.65 | $1,026,816.05 |
DisclosureSEC source: 0001209191-19-014755 · doc4.xml · nonDerivative · entry 2 Khalaf Michel · CIK 0001535491 · President, U.S. Bus. and EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,781 F1 · kind: Cash payout of 2016-2018 Performance Units, following determination of the performance factor for such award. Each Performance Unit is settled in cash equal to the closing price of one share of MetLife, Inc. common stock on the payout date. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 23:52 UTC |
Khalaf MichelPresident, U.S. Bus. and EMEA
|
GrantCommon Stock | 22,997 | $44.65 | $1,026,816.05 |
DisclosureSEC source: 0001209191-19-014755 · doc4.xml · nonDerivative · entry 1 Khalaf Michel · CIK 0001535491 · President, U.S. Bus. and EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,778 F1 · kind: Cash payout of 2016-2018 Performance Units, following determination of the performance factor for such award. Each Performance Unit is settled in cash equal to the closing price of one share of MetLife, Inc. common stock on the payout date. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 23:51 UTC |
KANDARIAN STEVEN ADirector · Chairman, President & CEO
|
GrantRestricted Stock Units · Derivative | 36,955 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-014754 · doc4.xml · derivative · entry 5 KANDARIAN STEVEN A · CIK 0001255728 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,955 Underlying: Common Stock · 36,955 shares Expires not disclosed F4 · derivative.exercise_price: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock. F5 · derivative.exercise_date: The Restricted Stock Units vest in three installments on March 2, 2020, March 1, 2021 and March 1, 2022. F5 · derivative.expiration_date: The Restricted Stock Units vest in three installments on March 2, 2020, March 1, 2021 and March 1, 2022. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 23:51 UTC |
KANDARIAN STEVEN ADirector · Chairman, President & CEO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 110,888 | $0.00 Strike: $44.65 | $0.00 |
DisclosureSEC source: 0001209191-19-014754 · doc4.xml · derivative · entry 4 KANDARIAN STEVEN A · CIK 0001255728 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,888 Underlying: Common Stock · 110,888 shares Expires 2029-02-25 F3 · derivative.exercise_date: The options become exercisable in three installments on February 26, 2020, 2021 and 2022. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 23:51 UTC |
KANDARIAN STEVEN ADirector · Chairman, President & CEO
|
Tax withholdingCommon Stock | 63,519 | $44.65 | $2,836,123.35 |
DisclosureSEC source: 0001209191-19-014754 · doc4.xml · nonDerivative · entry 2 KANDARIAN STEVEN A · CIK 0001255728 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 590,145 F2 · kind: Shares withheld to satisfy the Reporting Person's tax withholding obligation due on the Performance Share payout. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 23:51 UTC |
KANDARIAN STEVEN ADirector · Chairman, President & CEO
|
GrantCommon Stock | 134,145 | $44.65 | $5,989,574.25 |
DisclosureSEC source: 0001209191-19-014754 · doc4.xml · nonDerivative · entry 1 KANDARIAN STEVEN A · CIK 0001255728 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 653,664 F1 · kind: Shares acquired from the payout of the 2016-2018 Performance Share Award following determination of the performance factor for such award. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 23:51 UTC |
Goulart Steven JEVP & Chief Investment Officer
|
GrantRestricted Stock Units · Derivative | 13,438 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-014752 · doc4.xml · derivative · entry 4 Goulart Steven J · CIK 0001519833 · EVP & Chief Investment Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,438 Underlying: Common Stock · 13,438 shares Expires not disclosed F4 · derivative.exercise_price: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock. F5 · derivative.exercise_date: The Restricted Stock Units vest in three installments on March 2, 2020, March 1, 2021 and March 1, 2022. F5 · derivative.expiration_date: The Restricted Stock Units vest in three installments on March 2, 2020, March 1, 2021 and March 1, 2022. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 23:51 UTC |
Goulart Steven JEVP & Chief Investment Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 40,323 | $0.00 Strike: $44.65 | $0.00 |
DisclosureSEC source: 0001209191-19-014752 · doc4.xml · derivative · entry 3 Goulart Steven J · CIK 0001519833 · EVP & Chief Investment Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,323 Underlying: Common Stock · 40,323 shares Expires 2029-02-25 F3 · derivative.exercise_date: The options become exercisable in three installments on February 26, 2020, 2021 and 2022. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 23:51 UTC |
Goulart Steven JEVP & Chief Investment Officer
|
Tax withholdingCommon Stock | 13,881 | $44.65 | $619,786.65 |
DisclosureSEC source: 0001209191-19-014752 · doc4.xml · nonDerivative · entry 2 Goulart Steven J · CIK 0001519833 · EVP & Chief Investment Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,980 F2 · kind: Shares withheld to satisfy the Reporting Person's tax withholding obligation due on the Performance Share payout. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 23:51 UTC |
Goulart Steven JEVP & Chief Investment Officer
|
GrantCommon Stock | 31,939 | $44.65 | $1,426,076.35 |
DisclosureSEC source: 0001209191-19-014752 · doc4.xml · nonDerivative · entry 1 Goulart Steven J · CIK 0001519833 · EVP & Chief Investment Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,861 F1 · kind: Shares acquired from the payout of 2016-2018 Performance Share Award pursuant to the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 23:50 UTC |
GAUSTER STEPHEN WEVP & General Counsel
|
GrantRestricted Stock Units · Derivative | 4,032 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-014751 · doc4.xml · derivative · entry 3 GAUSTER STEPHEN W · CIK 0001709219 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,032 Underlying: Common Stock · 4,032 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock. F3 · derivative.exercise_date: The Restricted Stock Units vest in three installments on March 2, 2020, March 1, 2021 and March 1, 2022. F3 · derivative.expiration_date: The Restricted Stock Units vest in three installments on March 2, 2020, March 1, 2021 and March 1, 2022. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 23:50 UTC |
GAUSTER STEPHEN WEVP & General Counsel
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 12,097 | $0.00 Strike: $44.65 | $0.00 |
DisclosureSEC source: 0001209191-19-014751 · doc4.xml · derivative · entry 2 GAUSTER STEPHEN W · CIK 0001709219 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,097 Underlying: Common Stock · 12,097 shares Expires 2029-02-25 F1 · derivative.exercise_date: The options become exercisable in three installments on February 26, 2020, 2021 and 2022. Read SEC document |
| February 26, 2019 Filed May 1, 2019 01:27 UTC Amendment |
Lee EstherEVP & Chief Marketing Officer
|
Tax withholdingCommon Stock | 323 | $44.65 | $14,421.95 |
DisclosureSEC source: 0001209191-19-026692 · doc4a.xml · nonDerivative · entry 1 Lee Esther · CIK 0001585015 · EVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,190 F1 · kind: The Reporting Person earned 12,776 shares from 2016-2018 Performance Shares pursuant to the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. She deferred those shares under the MetLife Leadership Deferred Compensation Plan, which allows eligible employees to defer receipt of such stock for a specific period of time. The Company withheld 323 shares to satisfy withholding for FICA and Medicare taxes. These withheld shares were inadvertently omitted from the original, timely February 28, 2019 report of the Reporting Person's deferred share acquisition. F2 · balance_after: As a result of the inadvertent omission described in footnote (1), the amount of securities beneficially owned by the Reporting Person was incorrectly stated on the report filed on February 28, 2019. The amount in Table I box 5 of this report is the amount of ownership immediately following the transaction reported on this form. By this note, this report also corrects the amount of securities beneficially owned following each of the reported transactions in box 5 of Table I of the Reporting Person's report filed on March 5, 2019 to 28,619; 27,690; 29,468; 28,788; 30,107; and 29,602, respectively. Read SEC document |
| February 12, 2019 Filed Feb 13, 2019 21:39 UTC |
Goulart Steven JEVP & Chief Investment Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 15,671 | $0.00 Strike: $20.82 | $0.00 |
DisclosureSEC source: 0001209191-19-009659 · doc4.xml · derivative · entry 4 Goulart Steven J · CIK 0001519833 · EVP & Chief Investment Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,671 shares Expires 2019-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The options became exercisable in three installments on February 24, 2010, 2011, and 2012. Read SEC document |
| February 12, 2019 Filed Feb 13, 2019 21:39 UTC |
Goulart Steven JEVP & Chief Investment Officer
|
SaleCommon Stock | 4,592 | $44.40 | $203,898.58 |
DisclosureSEC source: 0001209191-19-009659 · doc4.xml · nonDerivative · entry 3 Goulart Steven J · CIK 0001519833 · EVP & Chief Investment Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,922 Read SEC document |
| February 12, 2019 Filed Feb 13, 2019 21:39 UTC |
Goulart Steven JEVP & Chief Investment Officer
|
SaleCommon Stock | 5,700 | $44.40 | $253,051.50 |
DisclosureSEC source: 0001209191-19-009659 · doc4.xml · nonDerivative · entry 2 Goulart Steven J · CIK 0001519833 · EVP & Chief Investment Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,514 Read SEC document |
| February 12, 2019 Filed Feb 13, 2019 21:39 UTC |
Goulart Steven JEVP & Chief Investment Officer
|
Exercise / conversionCommon Stock | 15,671 | $20.82 | $326,270.22 |
DisclosureSEC source: 0001209191-19-009659 · doc4.xml · nonDerivative · entry 1 Goulart Steven J · CIK 0001519833 · EVP & Chief Investment Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,214 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 12, 2019 Filed Feb 13, 2019 21:41 UTC |
McCallion John D.EVP & Chief Financial Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,861 | $0.00 Strike: $20.82 | $0.00 |
DisclosureSEC source: 0001209191-19-009670 · doc4.xml · derivative · entry 3 McCallion John D. · CIK 0001709116 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,861 shares Expires 2019-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The options became exercisable in three installments on February 24, 2010, 2011, and 2012. Read SEC document |
| February 12, 2019 Filed Feb 13, 2019 21:41 UTC |
McCallion John D.EVP & Chief Financial Officer
|
SaleCommon Stock | 2,669 | $44.43 | $118,591.68 |
DisclosureSEC source: 0001209191-19-009670 · doc4.xml · nonDerivative · entry 2 McCallion John D. · CIK 0001709116 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,869 Read SEC document |
| February 12, 2019 Filed Feb 13, 2019 21:41 UTC |
McCallion John D.EVP & Chief Financial Officer
|
Exercise / conversionCommon Stock | 3,861 | $20.82 | $80,386.02 |
DisclosureSEC source: 0001209191-19-009670 · doc4.xml · nonDerivative · entry 1 McCallion John D. · CIK 0001709116 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,538 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 21:36 UTC |
Kennard William EDirector
|
GrantCommon Stock | 900 | $41.67 | $37,503.00 |
DisclosureSEC source: 0001209191-19-002001 · doc4.xml · nonDerivative · entry 1 Kennard William E · CIK 0001198236 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,594.3414 F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specified period of time. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 21:30 UTC |
Herzog David LDirector
|
GrantCommon Stock | 900 | $41.67 | $37,503.00 |
DisclosureSEC source: 0001209191-19-001973 · doc4.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,609.2856 F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specific period of time. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 21:47 UTC |
MORRISON DENISE MDirector
|
GrantCommon Stock | 900 | $41.67 | $37,503.00 |
DisclosureSEC source: 0001209191-19-002032 · doc4.xml · nonDerivative · entry 1 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,534 F1 · kind: The Reporting Person acquired these shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 21:44 UTC |
MCKENZIE DIANADirector
|
GrantCommon Stock | 900 | $41.67 | $37,503.00 |
DisclosureSEC source: 0001209191-19-002021 · doc4.xml · nonDerivative · entry 1 MCKENZIE DIANA · CIK 0001754648 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,324.4636 F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specific period of time. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 21:41 UTC |
Kinney Catherine RDirector
|
GrantCommon Stock | 900 | $41.67 | $37,503.00 |
DisclosureSEC source: 0001209191-19-002016 · doc4.xml · nonDerivative · entry 1 Kinney Catherine R · CIK 0001205054 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,500.9319 F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specified period of time. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 21:39 UTC |
KILTS JAMES MDirector
|
GrantCommon Stock | 900 | $41.67 | $37,503.00 |
DisclosureSEC source: 0001209191-19-002009 · doc4.xml · nonDerivative · entry 1 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,564.2347 F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specified period of time. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 21:35 UTC |
KELLY EDWARD J IIIDirector
|
GrantCommon Stock | 900 | $41.67 | $37,503.00 |
DisclosureSEC source: 0001209191-19-001998 · doc4.xml · nonDerivative · entry 1 KELLY EDWARD J III · CIK 0001160225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,838.8599 F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specified period of time. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 21:33 UTC |
HUBBARD ROBERT GLENNDirector
|
GrantCommon Stock Equivalents · Derivative | 599.952 | $41.67 | $25,000.00 |
DisclosureSEC source: 0001209191-19-001988 · doc4.xml · derivative · entry 2 HUBBARD ROBERT GLENN · CIK 0001283051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 599.952 Underlying: Common Stock · 599.952 shares Expires not disclosed F2 · derivative.exercise_price: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F3 · kind: The Reporting Person acquired these Common Stock Equivalent Units pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. F2 · derivative.exercise_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F2 · derivative.expiration_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 21:33 UTC |
HUBBARD ROBERT GLENNDirector
|
GrantCommon Stock | 900 | $41.67 | $37,503.00 |
DisclosureSEC source: 0001209191-19-001988 · doc4.xml · nonDerivative · entry 1 HUBBARD ROBERT GLENN · CIK 0001283051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,085.0416 F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specified period of time. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 21:28 UTC |
HASSELL GERALD LDirector
|
GrantCommon Stock Equivalent Units · Derivative | 359.9712 | $41.67 | $15,000.00 |
DisclosureSEC source: 0001209191-19-001958 · doc4.xml · derivative · entry 3 HASSELL GERALD L · CIK 0001209482 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 359.9712 Underlying: Common Stock · 359.9712 shares Expires not disclosed F2 · derivative.exercise_price: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F3 · kind: The Reporting Person acquired these Common Stock Equivalent Units pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. F2 · derivative.exercise_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F2 · derivative.expiration_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 21:28 UTC |
HASSELL GERALD LDirector
|
GrantCommon Stock | 900 | $41.67 | $37,503.00 |
DisclosureSEC source: 0001209191-19-001958 · doc4.xml · nonDerivative · entry 1 HASSELL GERALD L · CIK 0001209482 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,563.8755 F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specific period of time. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 21:26 UTC |
GUTIERREZ CARLOS MDirector
|
GrantCommon Stock | 900 | $41.67 | $37,503.00 |
DisclosureSEC source: 0001209191-19-001950 · doc4.xml · nonDerivative · entry 1 GUTIERREZ CARLOS M · CIK 0001185943 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,568 F1 · kind: The Reporting Person acquired these shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 21:24 UTC |
GRISE CHERYL WDirector
|
GrantCommon Stock | 900 | $41.67 | $37,503.00 |
DisclosureSEC source: 0001209191-19-001937 · doc4.xml · nonDerivative · entry 1 GRISE CHERYL W · CIK 0001192342 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,199.4476 F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specific period of time. Read SEC document |
| December 17, 2018 Filed Dec 19, 2018 21:42 UTC |
GUTIERREZ CARLOS MDirector
|
PurchaseCommon Stock | 6,400 | $39.04 | $249,864.96 |
DisclosureSEC source: 0001209191-18-063499 · doc4.xml · nonDerivative · entry 2 GUTIERREZ CARLOS M · CIK 0001185943 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Carlos M. Gutierrez Trust Disclosed balance after: 18,807 F1 · price: The price reported is the weighted average price of the aggregate number of shares purchased in multiple open market transactions. The shares were purchased at prices $38.95 to $39.20, inclusive. The Reporting Person undertakes to provide to the staff of the SEC, MetLife, Inc., or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price. F2 · balance_after: 12,407 of these shares were previously reported as directly owned. Read SEC document |
| December 13, 2018 Filed Dec 14, 2018 21:31 UTC |
MCKENZIE DIANADirector
|
GrantCommon Stock | 4.4636 | $39.52 | $176.40 |
DisclosureSEC source: 0001209191-18-062732 · doc4.xml · nonDerivative · entry 1 MCKENZIE DIANA · CIK 0001754648 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 424.4636 F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred. Read SEC document |
| December 13, 2018 Filed Dec 14, 2018 21:30 UTC |
Kinney Catherine RDirector
|
GrantCommon Stock | 302.3173 | $39.52 | $11,947.58 |
DisclosureSEC source: 0001209191-18-062731 · doc4.xml · nonDerivative · entry 1 Kinney Catherine R · CIK 0001205054 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,600.9319 F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred. Read SEC document |
| December 13, 2018 Filed Dec 14, 2018 21:27 UTC |
KELLY EDWARD J IIIDirector
|
GrantCommon Stock | 136.0621 | $39.52 | $5,377.17 |
DisclosureSEC source: 0001209191-18-062728 · doc4.xml · nonDerivative · entry 1 KELLY EDWARD J III · CIK 0001160225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,938.8599 F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred. Read SEC document |
| December 13, 2018 Filed Dec 14, 2018 21:29 UTC |
KILTS JAMES MDirector
|
GrantCommon Stock Equivalent Units · Derivative | 120.8696 | $39.52 | $4,776.77 |
DisclosureSEC source: 0001209191-18-062730 · doc4.xml · derivative · entry 3 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120.8696 Underlying: Common Stock · 120.8696 shares Expires not disclosed F3 · derivative.exercise_price: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F4 · timeliness: Represents imputed reinvestment of dividends on Common Stock Equivalent Units. F3 · price: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F3 · derivative.exercise_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F3 · derivative.expiration_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. Read SEC document |
| December 13, 2018 Filed Dec 14, 2018 21:29 UTC |
KILTS JAMES MDirector
|
GrantCommon Stock | 536.8958 | $39.52 | $21,218.12 |
DisclosureSEC source: 0001209191-18-062730 · doc4.xml · nonDerivative · entry 1 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,664.2347 F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.